TRACE Study – Post-MI Heart Failure Risk (TRACE-inspired) Calculator
Enter the patient’s clinical features to calculate an educational, heuristic feature count. This is not an official TRACE score and does not provide a validated probability of future heart failure.
Patient characteristics
Complete all fields using the stated units.
About this estimator
The TRACE (Trandolapril Cardiac Evaluation) trial studied trandolapril in patients with left ventricular systolic dysfunction after myocardial infarction. It reported reductions in mortality and progression to severe heart failure with treatment; it was not the source of the heuristic point weights implemented here. Read the original trial on PubMed.
Features included in this prototype
| Feature | Heuristic rule | Points |
|---|---|---|
| Age | 65–74 years / ≥75 years | +1 / +2 |
| LVEF | ≤50%, with greater weight at ≤45% and ≤35% | +1 to +4 |
| Killip class | Class II / III / IV | +1 / +2 / +3 |
| Systolic BP | <100 mmHg | +1 |
| Heart rate | ≥100 beats/min | +1 |
| Creatinine | ≥1.5 or ≥2.0 mg/dL | +1 / +2 |
| Diabetes | Present | +1 |
| Anterior infarction | Present | +1 |
These weights are retained from the supplied prototype for transparency; they have not been established as a validated model.
Clinical use
Assess the patient’s actual haemodynamic status, symptoms and signs of heart failure, LV function, renal function, infarct characteristics, comorbidities, and evidence-based post-MI management needs. Consider validated prediction tools appropriate to the clinical question and population.
Evidence and references
These publications provide context for post-MI LV dysfunction and outcomes. They do not validate this tool’s point weights or category boundaries.
Clinical notes
Document key findings and keep a structured record for your own reference.
My notes
Review, edit, or remove notes saved in this browser.
Report an issue
Your feedback helps us improve the reliability and usability of this clinical tool.